180 related articles for article (PubMed ID: 11961478)
1. Modelling valuations for Eq-5d health states: an alternative model using differences in valuations.
Dolan P; Roberts J
Med Care; 2002 May; 40(5):442-6. PubMed ID: 11961478
[TBL] [Abstract][Full Text] [Related]
2. [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].
Lamers LM; Stalmeier PF; McDonnell J; Krabbe PF; van Busschbach JJ
Ned Tijdschr Geneeskd; 2005 Jul; 149(28):1574-8. PubMed ID: 16038162
[TBL] [Abstract][Full Text] [Related]
3. Valuations of EQ-5D health states: are the United States and United Kingdom different?
Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
[TBL] [Abstract][Full Text] [Related]
4. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
Kharroubi SA; O'Hagan A; Brazier JE
Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
[TBL] [Abstract][Full Text] [Related]
5. The impact of differences between patient and general population EQ-5D-3L values on the mean tariff scores of different patient groups.
Little MH; Reitmeir P; Peters A; Leidl R
Value Health; 2014 Jun; 17(4):364-71. PubMed ID: 24968996
[TBL] [Abstract][Full Text] [Related]
6. Effect of age on health state valuations.
Dolan P
J Health Serv Res Policy; 2000 Jan; 5(1):17-21. PubMed ID: 10787582
[TBL] [Abstract][Full Text] [Related]
7. Modeling valuations for EuroQol health states.
Dolan P
Med Care; 1997 Nov; 35(11):1095-108. PubMed ID: 9366889
[TBL] [Abstract][Full Text] [Related]
8. A comparison of injured patient and general population valuations of EQ-5D health states for New Zealand.
Wilson R; Hansen P; Langley J; Derrett S
Health Qual Life Outcomes; 2014 Feb; 12():21. PubMed ID: 24548314
[TBL] [Abstract][Full Text] [Related]
9. Aggregating health state valuations.
Dolan P
J Health Serv Res Policy; 1997 Jul; 2(3):160-5; discussion 166-7. PubMed ID: 10180377
[TBL] [Abstract][Full Text] [Related]
10. Patient versus general population health state valuations: a case study of non-specific low back pain.
van Dongen JM; van denBerg B; Bekkering GE; van Tulder MW; Ostelo RWJG
Qual Life Res; 2017 Jun; 26(6):1627-1633. PubMed ID: 28155048
[TBL] [Abstract][Full Text] [Related]
11. US valuation of the EQ-5D health states: development and testing of the D1 valuation model.
Shaw JW; Johnson JA; Coons SJ
Med Care; 2005 Mar; 43(3):203-20. PubMed ID: 15725977
[TBL] [Abstract][Full Text] [Related]
12. Quality-of-life valuations of advanced breast cancer by New Zealand women.
Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
[TBL] [Abstract][Full Text] [Related]
13. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.
Rivero-Arias O; Ouellet M; Gray A; Wolstenholme J; Rothwell PM; Luengo-Fernandez R
Med Decis Making; 2010; 30(3):341-54. PubMed ID: 19858500
[TBL] [Abstract][Full Text] [Related]
14. Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.
Harrison MJ; Davies LM; Bansback NJ; McCoy MJ; Farragher TM; Verstappen SM; Hassell A; Symmons DP
Value Health; 2009 Sep; 12(6):1026-34. PubMed ID: 19473335
[TBL] [Abstract][Full Text] [Related]
15. The social tariff of EQ-5D is not adequate to assess quality of life in patients with low back pain.
Zamora J; Kovacs F; Abraira V; Fernández C; Lázaro P;
Qual Life Res; 2007 Apr; 16(3):523-31. PubMed ID: 17111230
[TBL] [Abstract][Full Text] [Related]
16. Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.
Yang Z; Luo N; Bonsel G; Busschbach J; Stolk E
Value Health; 2019 Jan; 22(1):38-44. PubMed ID: 30661632
[TBL] [Abstract][Full Text] [Related]
17. Dutch Tariff for the Five-Level Version of EQ-5D.
M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E
Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions.
Rand-Hendriksen K; Augestad LA; Kristiansen IS; Stavem K
Qual Life Res; 2012 Aug; 21(6):1005-12. PubMed ID: 21932138
[TBL] [Abstract][Full Text] [Related]
19. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
20. Estimating an EQ-5D-5L Value Set for China.
Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]